Open AccessExperience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis
Author(s) -
Olga Boyko,
С. В. Петров,
N. Yu. Lashch,
М Е Гусева,
Alexey Boyко
Publication year - 2019
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2019-1-59-65
Subject(s) - ocrelizumab , medicine , multiple sclerosis , exacerbation , expanded disability status scale , rituximab , immunology , lymphoma